Evidence map›Paper›PMID 30419824›Full record

ArticleBMC genomics2018

Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.

Mary E Sweet, Andrea Cocciolo, Dobromir Slavov, Kenneth L Jones, Joseph R Sweet, Sharon L Graw, T Brett Reece, Amrut V Ambardekar, Michael R Bristow, Luisa Mestroni and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 4 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 4 syntheses or guidelines pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. RRAGD p.(Ser76Leu) Variant Causes Dysregulated Expression of Muscle Development and Cytoskeleton Genes in Cardiomyocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mary E SweetHuman Medical Genetics and Genomics, University of Colorado, Aurora, CO, USA.ORCID http://orcid.org/0000-0001-9496-3737
Andrea CoccioloCardiovascular Institute and Adult Medical Genetics Program, University of Colorado, Aurora, CO, USA.
Dobromir SlavovCardiovascular Institute and Adult Medical Genetics Program, University of Colorado, Aurora, CO, USA.
Kenneth L JonesDepartment of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplant, University of Colorado, Aurora, CO, USA.
Joseph R SweetDepartment of Statistics, E. & J. Gallo, Modesto, CA, USA.
Sharon L GrawCardiovascular Institute and Adult Medical Genetics Program, University of Colorado, Aurora, CO, USA.
T Brett ReeceDepartment of Cardiothoracic Surgery, University of Colorado Hospital, Aurora, CO, USA.
Amrut V AmbardekarDivision of Cardiology, Department of Medicine, University of Colorado, Aurora, CO, USA.
Michael R BristowDivision of Cardiology, Department of Medicine, University of Colorado, Aurora, CO, USA.
Luisa MestroniHuman Medical Genetics and Genomics, University of Colorado, Aurora, CO, USA.
Matthew R G TaylorHuman Medical Genetics and Genomics, University of Colorado, Aurora, CO, USA. matthew.taylor@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Hospital · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Molecular Epidemiology of Dilated CardiomyopathR01HL069071 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MESTRONI, LUISA · 2002 to 2005
$2.3M
Whole genome DNA sequencing to identify novel genes in dilated cardiomyopathyR01HL109209 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI TAYLOR, MATTHEW R · 2012 to 2016
$2.1M
Fondation Leducq 14-CVD 03National Institutes of Health R01 116906National Institutes of Health R01 HL109209National Institutes of Health R01 HL69071National Institutes of Health UL1 TR001082NCATS NIH HHS UL1 TR001082NHLBI NIH HHS R01 HL069071NHLBI NIH HHS R01 HL109209
6 · The paper itself

Abstract

backgroundCurrent heart failure (HF) treatment is based on targeting symptoms and left ventricle dysfunction severity, relying on a common HF pathway paradigm to justify common treatments for HF patients. This common strategy may belie an incomplete understanding of heterogeneous underlying mechanisms and could be a barrier to more precise treatments. We hypothesized we could use RNA-sequencing (RNA-seq) in human heart tissue to delineate HF etiology-specific gene expression signatures.

resultsRNA-seq from 64 human left ventricular samples: 37 dilated (DCM), 13 ischemic (ICM), and 14 non-failing (NF). Using a multi-analytic approach including covariate adjustment for age and sex, differentially expressed genes (DEGs) were identified characterizing HF and disease-specific expression. Pathway analysis investigated enrichment for biologically relevant pathways and functions. DCM vs NF and ICM vs NF had shared HF-DEGs that were enriched for the fetal gene program and mitochondrial dysfunction. DCM-specific DEGs were enriched for cell-cell and cell-matrix adhesion pathways. ICM-specific DEGs were enriched for cytoskeletal and immune pathway activation. Using the ICM and DCM DEG signatures from our data we were able to correctly classify the phenotypes of 24/31 ICM and 32/36 DCM samples from publicly available replication datasets.

conclusionsOur results demonstrate the commonality of mitochondrial dysfunction in end-stage HF but more importantly reveal key etiology-specific signatures. Dysfunctional cell-cell and cell-matrix adhesion signatures typified DCM whereas signals related to immune and fibrotic responses were seen in ICM. These findings suggest that transcriptome signatures may distinguish end-stage heart failure, shedding light on underlying biological differences between ICM and DCM.

Indexed as

Cell AdhesionImmunity, CellularBiomarkersCardiomyopathy, DilatedCase-Control StudiesFemaleGene Expression ProfilingHeart FailureHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMyocardial IschemiaTranscriptomeBiomarkersCardiomyopathyGene expressionHeart failureRNA-seqTranscriptome

Identifiers

PMID30419824
PMCPMC6233272
OpenAlexW2901071040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.